Balaxi Pharma Fact Sheet, Balaxi Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Balaxi Pharma Fact Sheet    (TARCL)


EV Gold Rush: Watch Now Before Investing Your Money in EV Stocks


Here is the latest financial fact sheet of Balaxi Pharma. For more details, see the Balaxi Pharma quarterly results and Balaxi Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

BALAXI PHARMA Price History

Price Rs 560.4
Mkt Cap Rs m 5,604
Vol '000 1.1
P/E X 14.0
P/CF X 91.7
EPS (TTM) Rs 40.2
% ch % -2.3
No. of shares m 10.00
% ch week % -1.1
% ch 1-mth % -2.0
% ch 12-mth % -34.3
52 week H/L Rs 905.0/500.0
(As on Oct 27, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BALAXI PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
BALAXI PHARMA EQUITY SHARE DATA
High Rs292536NANA 
Low Rs121217NANA 
Sales per share (Unadj.) Rs0.20044.745.6 
Earnings per share (Unadj.) Rs-0.3-0.6-2.56.56.1 
Diluted earnings per shareRs-0.1-0.2-0.82.06.1 
Cash flow per share (Unadj.) Rs-0.3-0.6-2.56.56.1 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %000NMNM 
Book value per share (Unadj.) Rs10.47.65.111.627.7 
Adj. book value per shareRs3.12.31.63.527.7 
Shares outstanding (eoy) m3.043.043.043.0410.00 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x129.3NMNM00 
Avg P/E ratio x-76.5-32.1-10.500 
P/CF ratio (eoy) x-78.5-32.4-10.500 
Price / Book Value ratio x2.02.45.200 
Dividend payout %00000 
Avg Mkt Cap Rs m61568100 
No. of employees `000NANANANANA 
Total wages/salary Rs m112921 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
BALAXI PHARMA INCOME DATA
Net Sales Rs m000136456 
Other income Rs m000928 
Total revenues Rs m000145484 
Gross profit Rs m-1-1-81661 
Depreciation Rs m00000 
Interest Rs m00000 
Profit before tax Rs m-1-2-82489 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m000528 
Profit after tax Rs m-1-2-82061 
Gross profit margin %-143.6NMNM11.513.4 
Effective tax rate %31.00019.431.2 
Net profit margin %-167.4NMNM14.513.4 
BALAXI PHARMA BALANCE SHEET DATA
Current assets Rs m3231658349 
Current liabilities Rs m4012682 
Net working cap to sales %-342.7NMNM23.558.4 
Current ratio x0.650.812.52.24.2 
Inventory Days Days25,005NMNM97 
Debtors Days Days154,167NMNM146,964237,680 
Net fixed assets Rs m3300311 
Share capital Rs m30303030100 
"Free" reserves Rs m1-7-155177 
Net worth Rs m31231635277 
Long term debt Rs m00000 
Total assets Rs m35241761360 
Interest coverage x-1.5-3.2NM1,221.0185.9 
Debt to equity ratio x00000 
Sales to assets ratio x0002.21.3 
Return on assets %-0.9-5.6-45.632.217.1 
Return on equity %-2.6-7.5-49.555.822.0 
Return on capital %-2.2-5.7-49.569.332.2 
Exports to sales %0NMNM00 
Imports to sales %0NMNM00 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m000136456 
Fx outflow Rs m000010 
Net fx Rs m000136447 
BALAXI PHARMA CASH FLOW
From Operations Rs m 0 -1 -7 -15 -141 
From Investments Rs m 1 27 0 0 -2 
From Financial Activity Rs m -1 -2 0 0 181 
Net Cashflow Rs m 0 23 -7 -15 39 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 72.9%
Institution 19.5%
Non-Institution 7.7%
Total 100.0%
Free Float 27.1%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Plot No.409 3rd Floor, Maps Towers Jubilee Hills, Road No:81, Hyderabad - 500096
E-MAIL info@balaxipharma.in WEB www.balaxipharma.in
TEL 040 23555300 FAX
SECTOR TRADING GROUP Private sector
TR AGENT SKDC Consultants Ltd, Kanapathy Towers 3rd Floor, Ganapathy
YEAR OF INC: 1942 NSE CODE: 98563236 FV (Rs): 10 DIV YIELD (%): -

More Trading Company Fact Sheets:   CADILA HEALTHCARE  AURO LAB.  THYROCARE TECHNOLOGIES  DR. REDDYS LAB  ASTER DM HEALTHCARE  

Compare BALAXI PHARMA With:   CADILA HEALTHCARE  AURO LAB.  THYROCARE TECHNOLOGIES  DR. REDDYS LAB  ASTER DM HEALTHCARE  




Today's Market

Sensex Ends 207 Points Lower as Metal & Banking Stocks Witness Selling; Axis Bank Tanks 7%(Closing)

Indian share markets witnessed volatile trading activity during closing hours today and ended lower.

Views on news

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Tata Group Stocks are on Fire: Which one Should You Buy? (Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

India's Big PSU Selloff: Watch Out for these Top Stocks (Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

Up 31,500% in a Year! This Packaging Company Sheds its Penny Stock Status (Views On News)

Oct 18, 2021

What's driving the relentless rally in this packaging company?

Insider Alert! Promoters are Increasing their Stakes in these 5 Companies (Views On News)

Oct 19, 2021

Promoters of many small and mid-cap companies are raising their stakes since the last few quarters.

The One Company Riding the Auto Revolution Beyond EVs (Profit Hunter)

Oct 22, 2021

It's not just about batteries taking over the internal combustion engine. Bigger disruptive forces are coming along with electrification.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BALAXI PHARMA

  • Track your investment in BALAXI PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BALAXI PHARMA

BALAXI PHARMA - BIJOY HANS COMPARISON

COMPARE BALAXI PHARMA WITH

MARKET STATS